Plasma homocysteine levels and mortality in patients with coronary artery disease

被引:1437
作者
Nygard, O
Nordrehaug, JE
Refsum, H
Ueland, PM
Farstad, M
Vollset, SE
机构
[1] UNIV BERGEN, DEPT PUBL HLTH & PRIMARY HLTH CARE, DIV MED STAT, BERGEN, NORWAY
[2] UNIV BERGEN, DEPT PHARMACOL, BERGEN, NORWAY
[3] UNIV BERGEN, DEPT BIOL CLIN, DIV BIOCHEM, BERGEN, NORWAY
关键词
D O I
10.1056/NEJM199707243370403
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Elevated plasma homocysteine levels are a risk factor for coronary heart disease, but the prognostic value of homocysteine levels in patients with established coronary artery disease has not been defined. Methods We prospectively investigated the relation between plasma total homocysteine levels and mortality among 587 patients with angiographically confirmed coronary artery disease. At the time of angiography in 1991 or 1992, risk factors for coronary disease, including homocysteine levels, were evaluated. The majority of the patients subsequently underwent coronary-artery bypass grafting (318 patients) or percutaneous transluminal coronary angioplasty (120 patients); the remaining 149 were treated medically. Results After a median follow-up of 4.6 years, 64 patients (10.9 percent) had died. We found a strong, graded relation between plasma homocysteine levels and overall mortality. After four years, 3.8 percent of patients with homocysteine levels below 9 mu mol per liter had died, as compared with 24.7 percent of those with homocysteine levels of 15 mu mol per liter or higher. Homocysteine levels were only weakly related to the extent of coronary artery disease but were strongly related to the history with respect to myocardial infarction, the left ventricular ejection fraction, and the serum creatinine level. The relation of homocysteine levels to mortality remained strong after adjustment for these and other potential confounders. In an analysis in which the patients with homocysteine levels below 9 mu mol per liter were used as the reference group, the mortality ratios were 1.9 for patients with homocysteine levels of 9.0 to 14.9 mu mol per liter, 2.8 for those with levels of 15.0 to 19.9 mu mol per liter, and 4.5 for those with levels of 20.0 mu mol per liter or higher (P for trend = 0.02). When death due to cardiovascular disease (which occurred in 50 patients) was used as the end point in the analysis, the relation between homocysteine levels and mortality was slightly strengthened. Conclusions Plasma total homocysteine levels are a strong predictor of mortality in patients with angiographically confirmed coronary artery disease. (C)1997, Massachusetts Medical Society.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 41 条
[1]   RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY [J].
ALFTHAN, G ;
PEKKANEN, J ;
JAUHIAINEN, M ;
PITKANIEMI, J ;
KARVONEN, M ;
TUOMILEHTO, J ;
SALONEN, JT ;
EHNHOLM, C .
ATHEROSCLEROSIS, 1994, 106 (01) :9-19
[2]   REVIEW OF SURVIVAL ANALYSES PUBLISHED IN CANCER JOURNALS [J].
ALTMAN, DG ;
DESTAVOLA, BL ;
LOVE, SB ;
STEPNIEWSKA, KA .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :511-518
[3]   SERUM TOTAL HOMOCYSTEINE AND CORONARY HEART-DISEASE [J].
ARNESEN, E ;
REFSUM, H ;
BONAA, KH ;
UELAND, PM ;
FORDE, OH ;
NORDREHAUG, JE .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) :704-709
[4]  
BOSTOM AG, IN PRESS KIDNEY INT
[5]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[6]   Vitamins as homocysteine-lowering agents [J].
Brattstrom, L .
JOURNAL OF NUTRITION, 1996, 126 (04) :S1276-S1280
[7]   METABOLIC ABNORMALITIES DETECTED IN A SURVEY OF MENTALLY BACKWARD INDIVIDUALS IN NORTHERN IRELAND [J].
CARSON, NAJ ;
NEILL, DW .
ARCHIVES OF DISEASE IN CHILDHOOD, 1962, 37 (195) :505-&
[8]   HOMOCYSTEINE AND CORONARY-ARTERY DISEASE IN FRENCH-CANADIAN SUBJECTS - RELATION WITH VITAMINS B-12, B-6, PYRIDOXAL-PHOSPHATE, AND FOLATE [J].
DALERY, K ;
LUSSIERCACAN, S ;
SELHUB, J ;
DAVIGNON, J ;
LATOUR, Y ;
GENEST, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (16) :1107-1111
[9]   Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].
denHeijer, M ;
Koster, T ;
Blom, HJ ;
Bos, GMJ ;
Briet, E ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762
[10]  
DIXON WJ, 1992, BMDP STATISTICAL SOF